| Keith James Leavell, MD | |
|
1200 6th Ave N, Centracare Clinic, Saint Cloud, MN 56303-2735 | |
| (320) 252-5131 | |
| (320) 240-2118 |
| Full Name | Keith James Leavell |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 36 Years |
| Location | 1200 6th Ave N, Saint Cloud, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184606311 | NPI | - | NPPES |
| 1011246 | Other | PREFERRED ONE | |
| 597042 | Other | ARAZ GROUP | |
| 112115 | Other | U CARE | |
| COMP | Other | MMSI | |
| 110122640 | Other | RR MEDICARE | |
| 597042 | Other | AMERICAS PPO | |
| 928880500 | Other | MEDICAL ASSISTANCE MA | |
| COMP | Other | ONE HEALTH PLAN | |
| COMP | Other | GREAT WEST | |
| HP10860 | Other | HEALTH PARTNERS | |
| COMP | Other | CHAMPUS | |
| 4800134 | Other | MEDICA HEALTH PLANS | |
| C11369 | Other | RR MEDICARE | |
| 27T22LE | Other | BLUE CROSS BLUE SHIELD | |
| 2114069 | Other | FIRST HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 34628 (Minnesota) | Primary |
| 207RS0012X | Internal Medicine - Sleep Medicine | 34628 (Minnesota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Cloud Hospital | Saint cloud, MN | Hospital |
| Centracare Health - Monticello | Monticello, MN | Hospital |
| Alomere Health | Alexandria, MN | Hospital |
| Carris Health - Redwood, Llc | Redwood falls, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centracare Clinic | 2466363395 | 632 |
News Archive
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease.
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.
A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 1 days ago
| Entity Name | Centracare Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043212665 PECOS PAC ID: 2466363395 Enrollment ID: O20031105000293 |
News Archive
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease.
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.
A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 1 days ago
| Entity Name | Mille Lacs Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548212699 PECOS PAC ID: 4789577834 Enrollment ID: O20040204000052 |
News Archive
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease.
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.
A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 1 days ago
| Entity Name | St Cloud Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043269798 PECOS PAC ID: 4880594779 Enrollment ID: O20110221000134 |
News Archive
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease.
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.
A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith James Leavell, MD 1200 6th Ave N, Centracare Clinic, Saint Cloud, MN 56303-2735 Ph: (320) 252-5131 | Keith James Leavell, MD 1200 6th Ave N, Centracare Clinic, Saint Cloud, MN 56303-2735 Ph: (320) 252-5131 |
News Archive
In rare cases, people who have been fully vaccinated against COVID and are immune to the virus can nevertheless develop the disease.
Patients treated with a new investigational combination pill showed significant improvements in cholesterol, triglycerides and other key lipids that lead to heart disease, according to results presented at the American Heart Association's Scientific Sessions.
A high pressure work deadline boosts the chances of a heart attack within the next 24 hours by a factor of six, reveals research in the Journal of Epidemiology and Community Health.
Medinox, Inc. in Carlsbad, California and Orient Europharma in Taiwan announce today that they have entered into a partnering agreement to develop and market NOX-100, a new anti-hypotensive drug. Under the terms of the agreement, Orient Europharma holds the exclusive distribution rights of NOX-100 in Taiwan, China, Korea, Australia, New Zealand and Southeast Asia. Medinox retains the marketing rights in the United States, Japan and Europe.
› Verified 1 days ago
Bradley E Currier, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1900 Centracare Cir, Saint Cloud, MN 56303 Phone: 320-240-2205 Fax: 320-229-5174 | |
Bharath Manu Akkara Veetil, MBBS Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 | |
Kamiab Delfanian, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1900 Centracare Cir, Suite 2400, Saint Cloud, MN 56303 Phone: 320-229-5099 Fax: 320-229-5171 | |
Jyh-yau Tsaur, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 | |
John D Olsen, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 | |
Mark J Martone, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 6th Ave N, Saint Cloud, MN 56303 Phone: 320-252-5131 Fax: 320-240-2118 | |
Matthew Eggebrecht, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1406 6th Ave N, Saint Cloud, MN 56303 Phone: 320-251-2700 |